Cherry Bekaert audit partner facing SEC scrutiny over MiMedx fraud case

Accountingbestpractices

The Securities and Exchange Commission is considering whether to pursue enforcement against a certified public accountant for his alleged role in an accounting fraud case the agency brought against biotech company MiMedx Group.

WELCOME TO OUR OPEN HOUSE – LOG IN TO CONTINUE READING FOR FREE

If you are already a registered user or a member, SIGN IN now.